Eudaimonia Partners, LLC Cytosorbents Corp Transaction History

Eudaimonia Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	BUY	$2.37 - $3.65 $8,295 - $12,775	3,500 Added 17.5%	23,500 $84,000
Q4 2022 Jan 24, 2023	BUY	$1.03 - $2.03 $9,270 - $18,270	9,000 Added 81.82%	20,000 $0
Q2 2022 Aug 09, 2022	BUY	$1.76 - $3.22 $19,360 - $35,420	11,000 New	11,000 $24,000
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $30,200 - $37,680	-4,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $24,690 - $34,440	-3,000 Reduced 42.86%	4,000 $35,000
Q3 2020 Nov 23, 2020	BUY	$7.37 - $11.54 $37,542 - $58,784	5,094 Added 267.26%	7,000 $56,000
Q3 2020 Nov 16, 2020	SELL	$7.37 - $11.54 $37,542 - $58,784	-5,094 Reduced 72.77%	1,906 $634,000
Q1 2020 May 05, 2020	BUY	$3.77 - $7.73 $26,390 - $54,110	7,000 New	7,000 $54,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.